Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jordan Elm

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
Epilepsia|September 5, 2013
The established status epilepticus trial 2013Thomas Bleck, Hannah Cock, James Chamberlain, et al.
The New England Journal of Medicine|November 28, 2019
Randomized Trial of Three Anticonvulsant Medications for Status EpilepticusJaideep Kapur, Jordan Elm, James M Chamberlain, et al.
Epilepsy & Behavior : E&B|October 27, 2019
Lessons from the Established Status Epilepticus Treatment TrialHannah R Cock, Lisa D Coles, Jordan Elm, et al.
Journal of the American Heart Association|April 23, 2025
History of Cancer and Atrial Cardiopathy: A Secondary Analysis of the ARCADIA Clinical TrialBabak B Navi, Mitchell S V Elkind, Cenai Zhang, et al.
Journal of Parkinson'S Disease|October 8, 2015
Peripheral Biomarkers of Parkinson's Disease Progression and Pioglitazone EffectsDavid K Simon, Tanya Simuni, Jordan Elm, et al.
Annals of Emergency Medicine|March 20, 2012
An overview of the adaptive designs accelerating promising trials into treatments (ADAPT-IT) projectWilliam J Meurer, Roger J Lewis, Danilo Tagle, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|August 24, 2021
Recombinant factor VIIa for hemorrhagic stroke treatment at earliest possible time (FASTEST): Protocol for a phase III, double-blind, randomized, placebo-controlled trialAndrew M Naidech, James Grotta, Jordan Elm, et al.
JAMA Neurology|August 18, 2025
Intravenous Argatroban or Eptifibatide in Patients Undergoing Mechanical Thrombectomy: A Subgroup Analysis of the MOST Randomized Clinical TrialIan Rines, Opeolu Adeoye, Andrew D Barreto, et al.
Lancet (London, England)|March 24, 2020
Efficacy of levetiracetam, fosphenytoin, and valproate for established status epilepticus by age group (ESETT): a double-blind, responsive-adaptive, randomised controlled trialJames M Chamberlain, Jaideep Kapur, Shlomo Shinnar, et al.
Neurology|October 10, 2025
Thrombolysis Alone vs With Argatroban or Eptifibatide: A Prespecified Subgroup Analysis of the MOST TrialAkash Roy, Jordan Elm, James R Ingles, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Epilepsia|September 5, 2013
The established status epilepticus trial 2013Thomas Bleck, Hannah Cock, James Chamberlain, et al.
The New England Journal of Medicine|November 28, 2019
Randomized Trial of Three Anticonvulsant Medications for Status EpilepticusJaideep Kapur, Jordan Elm, James M Chamberlain, et al.
Epilepsy & Behavior : E&B|October 27, 2019
Lessons from the Established Status Epilepticus Treatment TrialHannah R Cock, Lisa D Coles, Jordan Elm, et al.
Journal of the American Heart Association|April 23, 2025
History of Cancer and Atrial Cardiopathy: A Secondary Analysis of the ARCADIA Clinical TrialBabak B Navi, Mitchell S V Elkind, Cenai Zhang, et al.
Journal of Parkinson'S Disease|October 8, 2015
Peripheral Biomarkers of Parkinson's Disease Progression and Pioglitazone EffectsDavid K Simon, Tanya Simuni, Jordan Elm, et al.
Annals of Emergency Medicine|March 20, 2012
An overview of the adaptive designs accelerating promising trials into treatments (ADAPT-IT) projectWilliam J Meurer, Roger J Lewis, Danilo Tagle, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|August 24, 2021
Recombinant factor VIIa for hemorrhagic stroke treatment at earliest possible time (FASTEST): Protocol for a phase III, double-blind, randomized, placebo-controlled trialAndrew M Naidech, James Grotta, Jordan Elm, et al.
JAMA Neurology|August 18, 2025
Intravenous Argatroban or Eptifibatide in Patients Undergoing Mechanical Thrombectomy: A Subgroup Analysis of the MOST Randomized Clinical TrialIan Rines, Opeolu Adeoye, Andrew D Barreto, et al.
Lancet (London, England)|March 24, 2020
Efficacy of levetiracetam, fosphenytoin, and valproate for established status epilepticus by age group (ESETT): a double-blind, responsive-adaptive, randomised controlled trialJames M Chamberlain, Jaideep Kapur, Shlomo Shinnar, et al.
Neurology|October 10, 2025
Thrombolysis Alone vs With Argatroban or Eptifibatide: A Prespecified Subgroup Analysis of the MOST TrialAkash Roy, Jordan Elm, James R Ingles, et al.
Pageof 5